ROR1 and non-small cell lung carcinoma: ROR1 CAR-T cells also expanded in the blood, but infiltrated the lung tumors poorly, and had upregulation of inhibitory receptors on the T cells resembling the situation of ROR1 CAR-T cells founded in NSCLC patients in the above clinical trial.